Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Arzerra
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Symptom changes in multiple sclerosis following psychological interventions: a systematic review.
Thrombotic microangiopathy associated with interferon beta.
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis.
Oxidative modification of serum proteins in multiple sclerosis.
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Biogen Idec's PLEGRIDY™ (peginterferon beta-1a) approved in the US for the treatment of multiple sclerosis
Enzon presents pre-clinical data on controlled release of PEGylated interferon-beta-1b and PEGylated anti-TNF-a antibody fragment at the Controlled Release Society annual meeting
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
The Inaugural Hillel Panitch, MD Multiple Sclerosis Symposium
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.

Pages